How to Improve the Capturing of Antibody Fragments

contributed by Tosoh | 04/06/2021

Since 1986 and the first approval of therapeutic monoclonal antibody (mAb), the biopharmaceutical industry discovered a broad spectrum of diagnostic and therapeutic applications using antibody engineering. Some of the latest promising developments rely on antibody fragments. Antibody fragments are either separate functional subunits of antibodies or recombinant molecules, which, just like antibodies, are composed of immunoglobulin domains. The most popular fragments are Fab (Fragment antigen binding), scFv (single-chain Fragment variable), diabodies, and nanobodies^[1].

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.